Jesús Carlos Briones Garduño
Research Subjects
Jesús Carlos Briones Garduño has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
Carlos Gabriel Briones Vega
3 shared publications- Galileo Escobedo
Laboratorio de Inmunometabolismo, División de Investigación, Hospital General de México, Dr. Eduardo Liceaga, Mexico City, Mexico
3 shared publications - José Alfredo Aguayo-Guerrero
Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico
3 shared publications Yolanda Flores Cánovas
Indicaciones de cesárea en el sector público vs sector privado en el Estado de México Campus Universitario Siglo XXI. Toluca de Lerdo Estado de México México
3 shared publicationsBerenice Zavala-Barrios
Hospital General de México Dr. Eduardo Liceaga. Ciudad de México, México
2 shared publicationsJesús Carlos
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by GRAPHIMEDIC SA DE CV in Archivos de Investigación Materno Infantil
- Vol. 16 (1) , 32-36
Indicaciones de cesárea en el sector público vs sector privado en el Estado de México
- 1 January 2025
- Published by GRAPHIMEDIC SA DE CV in Archivos de Investigación Materno Infantil
- Vol. 16 (1) , 32-36
Open AccessIndicaciones de cesárea en el sector público vs sector privado en el Estado de México
- Open Access
- 1 January 2025
- Published by GRAPHIMEDIC SA DE CV in Archivos de Investigación Materno Infantil
- Vol. 16 (1) , 28-31
Escala FullPIERS como predictora de resultados adversos en pacientes con preeclampsia severa
Introducción: los trastornos hipertensivos del embarazo representan la complicación más común durante la gestación, con una frecuencia de hasta el 15% de los casos. Se considera una de las principales causas de mortalidad materna, con una incidencia en América Latina del 25.7%. La importancia de un diagnóstico oportuno radica en la elevada tasa de complicaciones maternas y fetales. En este contexto, surgió el modelo FullPIERS, una escala que permite predecir complicaciones maternas dentro de las primeras 48 horas de ingreso a la unidad hospitalaria. Objetivo: determinar la utilidad de la escala FullPIERS para predecir resultados adversos maternos en pacientes con diagnóstico de preeclampsia severa en el Hospital General «Dr. Maximiliano Ruiz Castañeda». Material y métodos: se realizó un análisis descriptivo relacional. Se identificó la información necesaria en los expedientes de pacientes que cumplieron con los criterios de inclusión. Para las variables cualitativas se realizó cálculo de frecuencias y porcentajes, y para las variables cuantitativas, cálculo de medidas de tendencia central y medidas de dispersión. Las medidas de probabilidad fueron sensibilidad, especificidad,
- 1 January 2025
- Published by GRAPHIMEDIC SA DE CV in Archivos de Investigación Materno Infantil
- Vol. 16 (1) , 28-31
Open AccessEscala FullPIERS como predictora de resultados adversos en pacientes con preeclampsia severa
Introducción: los trastornos hipertensivos del embarazo representan la complicación más común durante la gestación, con una frecuencia de hasta el 15% de los casos. Se considera una de las principales causas de mortalidad materna, con una incidencia en América Latina del 25.7%. La importancia de un diagnóstico oportuno radica en la elevada tasa de complicaciones maternas y fetales. En este contexto, surgió el modelo FullPIERS, una escala que permite predecir complicaciones maternas dentro de las primeras 48 horas de ingreso a la unidad hospitalaria. Objetivo: determinar la utilidad de la escala FullPIERS para predecir resultados adversos maternos en pacientes con diagnóstico de preeclampsia severa en el Hospital General «Dr. Maximiliano Ruiz Castañeda». Material y métodos: se realizó un análisis descriptivo relacional. Se identificó la información necesaria en los expedientes de pacientes que cumplieron con los criterios de inclusión. Para las variables cualitativas se realizó cálculo de frecuencias y porcentajes, y para las variables cuantitativas, cálculo de medidas de tendencia central y medidas de dispersión. Las medidas de probabilidad fueron sensibilidad, especificidad,
- Open Access
Maternal Consumption of Non-Nutritive Sweeteners during Pregnancy Is Associated with Alterations in the Colostrum Microbiota
Non-nutritive sweeteners (NNSs) provide a sweet taste to foods and beverages without significantly adding calories. Still, their consumption has been linked to modifications in adult’s and children’s gut microbiota and the disruption of blood glucose control. Human milk microbiota are paramount in establishing infants’ gut microbiota, but very little is known about whether the consumption of sweeteners can alter it. To address this question, we sequenced DNA extracted colostrum samples from a group of mothers, who had different levels of NNS consumption, using the Ion Torrent Platform. Our results show that the “core” of colostrum microbiota, composed of the genera Bifidobacterium, Blautia, Cutibacteium, Staphylococcus, and Streptococcus, remains practically unchanged with the consumption of NNS during pregnancy, but specific genera display significant alterations, such as Staphylococcus and Streptococcus. A significant increase in the unclassified archaea Methanobrevibacter spp. was observed as the consumption frequency of NNS increased. The increase in the abundance of this archaea has been previously linked to obesity in Mexican children. NNS consumption during pregnancy could be related to changes in colostrum microbiota and may affect infants’ gut microbiota seeding and their future health.
Open AccessMaternal Consumption of Non-Nutritive Sweeteners during Pregnancy Is Associated with Alterations in the Colostrum Microbiota
Non-nutritive sweeteners (NNSs) provide a sweet taste to foods and beverages without significantly adding calories. Still, their consumption has been linked to modifications in adult’s and children’s gut microbiota and the disruption of blood glucose control. Human milk microbiota are paramount in establishing infants’ gut microbiota, but very little is known about whether the consumption of sweeteners can alter it. To address this question, we sequenced DNA extracted colostrum samples from a group of mothers, who had different levels of NNS consumption, using the Ion Torrent Platform. Our results show that the “core” of colostrum microbiota, composed of the genera Bifidobacterium, Blautia, Cutibacteium, Staphylococcus, and Streptococcus, remains practically unchanged with the consumption of NNS during pregnancy, but specific genera display significant alterations, such as Staphylococcus and Streptococcus. A significant increase in the unclassified archaea Methanobrevibacter spp. was observed as the consumption frequency of NNS increased. The increase in the abundance of this archaea has been previously linked to obesity in Mexican children. NNS consumption during pregnancy could be related to changes in colostrum microbiota and may affect infants’ gut microbiota seeding and their future health.
- Open Access
The Colloido-Osmotic Pressure as a useful biomarker of fatal outcome in pregnant COVID-19 patients
Background: Pregnancy was considering a health condition that could support high severity in COVID-19, among others the cardiologic and respiratory systems express some physiologic change in the pregnant women and could specially affected in COVID-19. Pregnant women characteristically have an increase volume of blood, with a higher cardiac output and lower peripheral vascular resistance, these could be negative affected by hypoalbuminemia frequently observed in COVID-19. Then, an early recognition of hypoalbuminemia in pregnant women with COVID-19 would help us to predict fatal outcome. Objective: We conduct a study to analyzed the demographic, clinical, blood gas test results, laboratory and ultrasonographic doppler data in pregnant women with COVID-19 that demand medical attention for labor. Study design: Ninety-two pregnant women with COVID-19 were included in our study from may 30 th 2020 to august 12 th 2022, and data was analyzed in survival and fatal outcome patients. Normality test were applied to data and parametric or non-parametric test were used to determine statistical difference between or among data. Results: Demographic and clinical data were quite similar between survival and fatal outcome pregnant patients with COVID-19. Also, blood gas test shown similar results among groups (asymptomatic, mild, or severe patients who survive COVID-19 or fatal outcome patients). We observed that serum albumin was consistently low in pregnant patients with fatal outcome by COVID-19, then based on Total Protein concentration in serum we calculated the colloido-osmotic pressure and we evaluate its utility as predictor of fatal outcome. ROC analysis and Kaplan-Meier of survival curves suggest that the colloido-osmotic pressure could be a potential predictor. Also, we observed an association of low colloido-osmotic pressure and low amniotic fluid index. Conclusion: Our study suggests that early evaluation of pregnant with COVID-19 must include the calculation of colloido-osmotic pressure and the doppler analysis to early recognition of fatal outcome in pregnant women with COVID-19.
Open AccessThe Colloido-Osmotic Pressure as a useful biomarker of fatal outcome in pregnant COVID-19 patients
Background: Pregnancy was considering a health condition that could support high severity in COVID-19, among others the cardiologic and respiratory systems express some physiologic change in the pregnant women and could specially affected in COVID-19. Pregnant women characteristically have an increase volume of blood, with a higher cardiac output and lower peripheral vascular resistance, these could be negative affected by hypoalbuminemia frequently observed in COVID-19. Then, an early recognition of hypoalbuminemia in pregnant women with COVID-19 would help us to predict fatal outcome. Objective: We conduct a study to analyzed the demographic, clinical, blood gas test results, laboratory and ultrasonographic doppler data in pregnant women with COVID-19 that demand medical attention for labor. Study design: Ninety-two pregnant women with COVID-19 were included in our study from may 30 th 2020 to august 12 th 2022, and data was analyzed in survival and fatal outcome patients. Normality test were applied to data and parametric or non-parametric test were used to determine statistical difference between or among data. Results: Demographic and clinical data were quite similar between survival and fatal outcome pregnant patients with COVID-19. Also, blood gas test shown similar results among groups (asymptomatic, mild, or severe patients who survive COVID-19 or fatal outcome patients). We observed that serum albumin was consistently low in pregnant patients with fatal outcome by COVID-19, then based on Total Protein concentration in serum we calculated the colloido-osmotic pressure and we evaluate its utility as predictor of fatal outcome. ROC analysis and Kaplan-Meier of survival curves suggest that the colloido-osmotic pressure could be a potential predictor. Also, we observed an association of low colloido-osmotic pressure and low amniotic fluid index. Conclusion: Our study suggests that early evaluation of pregnant with COVID-19 must include the calculation of colloido-osmotic pressure and the doppler analysis to early recognition of fatal outcome in pregnant women with COVID-19.
- Open Access
- 21 February 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (3) , 650
Newborns from Mothers Who Intensely Consumed Sucralose during Pregnancy Are Heavier and Exhibit Markers of Metabolic Alteration and Low-Grade Systemic Inflammation: A Cross-Sectional, Prospective Study
Robust data in animals show that sucralose intake during gestation can predispose the offspring to weight gain, metabolic disturbances, and low-grade systemic inflammation; however, concluding information remains elusive in humans. In this cross-sectional, prospective study, we examined the birth weight, glucose and insulin cord blood levels, monocyte subsets, and inflammatory cytokine profile in 292 neonates at term from mothers with light sucralose ingestion (LSI) of less than 60 mg sucralose/week or heavy sucralose intake (HSI) of more than 36 mg sucralose/day during pregnancy. Mothers in the LSI (n = 205) or HSI (n = 87) groups showed no differences in age, pregestational body mass index, blood pressure, and glucose tolerance. Although there were no differences in glucose, infants from HSI mothers displayed significant increases in birth weight and insulin compared to newborns from LSI mothers. Newborns from HSI mothers showed a substantial increase in the percentage of inflammatory nonclassical monocytes compared to neonates from LSI mothers. Umbilical cord tissue of infants from HSI mothers exhibited higher IL-1 beta and TNF-alpha with lower IL-10 expression than that found in newborns from LSI mothers. Present results demonstrate that heavy sucralose ingestion during pregnancy affects neonates’ anthropometric, metabolic, and inflammatory features.
- 21 February 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (3) , 650
Open AccessNewborns from Mothers Who Intensely Consumed Sucralose during Pregnancy Are Heavier and Exhibit Markers of Metabolic Alteration and Low-Grade Systemic Inflammation: A Cross-Sectional, Prospective Study
Robust data in animals show that sucralose intake during gestation can predispose the offspring to weight gain, metabolic disturbances, and low-grade systemic inflammation; however, concluding information remains elusive in humans. In this cross-sectional, prospective study, we examined the birth weight, glucose and insulin cord blood levels, monocyte subsets, and inflammatory cytokine profile in 292 neonates at term from mothers with light sucralose ingestion (LSI) of less than 60 mg sucralose/week or heavy sucralose intake (HSI) of more than 36 mg sucralose/day during pregnancy. Mothers in the LSI (n = 205) or HSI (n = 87) groups showed no differences in age, pregestational body mass index, blood pressure, and glucose tolerance. Although there were no differences in glucose, infants from HSI mothers displayed significant increases in birth weight and insulin compared to newborns from LSI mothers. Newborns from HSI mothers showed a substantial increase in the percentage of inflammatory nonclassical monocytes compared to neonates from LSI mothers. Umbilical cord tissue of infants from HSI mothers exhibited higher IL-1 beta and TNF-alpha with lower IL-10 expression than that found in newborns from LSI mothers. Present results demonstrate that heavy sucralose ingestion during pregnancy affects neonates’ anthropometric, metabolic, and inflammatory features.
- Open Access
- 9 February 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (2) , 410
Environmental Nanoparticles Reach Human Fetal Brains
Anthropogenic ultrafine particulate matter (UFPM) and industrial and natural nanoparticles (NPs) are ubiquitous. Normal term, preeclamptic, and postconceptional weeks(PCW) 8–15 human placentas and brains from polluted Mexican cities were analyzed by TEM and energy-dispersive X-ray spectroscopy. We documented NPs in maternal erythrocytes, early syncytiotrophoblast, Hofbauer cells, and fetal endothelium (ECs). Fetal ECs exhibited caveolar NP activity and widespread erythroblast contact. Brain ECs displayed micropodial extensions reaching luminal NP-loaded erythroblasts. Neurons and primitive glia displayed nuclear, organelle, and cytoplasmic NPs in both singles and conglomerates. Nanoscale Fe, Ti, and Al alloys, Hg, Cu, Ca, Sn, and Si were detected in placentas and fetal brains. Preeclamptic fetal blood NP vesicles are prospective neonate UFPM exposure biomarkers. NPs are reaching brain tissues at the early developmental PCW 8–15 stage, and NPs in maternal and fetal placental tissue compartments strongly suggests the placental barrier is not limiting the access of environmental NPs. Erythroblasts are the main early NP carriers to fetal tissues. The passage of UFPM/NPs from mothers to fetuses is documented and fingerprinting placental single particle composition could be useful for postnatal risk assessments. Fetal brain combustion and industrial NPs raise medical concerns about prenatal and postnatal health, including neurological and neurodegenerative lifelong consequences.
- 9 February 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (2) , 410
Open AccessEnvironmental Nanoparticles Reach Human Fetal Brains
Anthropogenic ultrafine particulate matter (UFPM) and industrial and natural nanoparticles (NPs) are ubiquitous. Normal term, preeclamptic, and postconceptional weeks(PCW) 8–15 human placentas and brains from polluted Mexican cities were analyzed by TEM and energy-dispersive X-ray spectroscopy. We documented NPs in maternal erythrocytes, early syncytiotrophoblast, Hofbauer cells, and fetal endothelium (ECs). Fetal ECs exhibited caveolar NP activity and widespread erythroblast contact. Brain ECs displayed micropodial extensions reaching luminal NP-loaded erythroblasts. Neurons and primitive glia displayed nuclear, organelle, and cytoplasmic NPs in both singles and conglomerates. Nanoscale Fe, Ti, and Al alloys, Hg, Cu, Ca, Sn, and Si were detected in placentas and fetal brains. Preeclamptic fetal blood NP vesicles are prospective neonate UFPM exposure biomarkers. NPs are reaching brain tissues at the early developmental PCW 8–15 stage, and NPs in maternal and fetal placental tissue compartments strongly suggests the placental barrier is not limiting the access of environmental NPs. Erythroblasts are the main early NP carriers to fetal tissues. The passage of UFPM/NPs from mothers to fetuses is documented and fingerprinting placental single particle composition could be useful for postnatal risk assessments. Fetal brain combustion and industrial NPs raise medical concerns about prenatal and postnatal health, including neurological and neurodegenerative lifelong consequences.
- Open Access
- 11 January 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (1) , 8
Chagas Disease in Pregnant Women from Endemic Regions Attending the Hospital General de Mexico, Mexico City
Trypanosoma cruzi infection leads to Chagas disease (CD), a neglected tropical infection of significant public health importance in South and Central America and other, non-endemic, countries. Pregnant women and their children are of particular importance to screen as T. cruzi can be transmitted vertically. The objective of this study was to screen for T. cruzi infection among pregnant women from endemic areas seen at the Hospital General de Mexico for prenatal care, so that they and their children may be quickly connected to CD treatment. Pregnant women were recruited through the hospital prenatal clinic and screened for T. cruzi infection using a series of serological and molecular tests. Of 150 screened patients, mean age 26.8 (SD 6.4), 30 (20.0%) were positive by at least one diagnostic test. Of these, only nine (6%) were positive as determined by PCR. Diagnosis of chronic CD is difficult in endemic places like Mexico due to the limitations of current commercially available diagnostic tests. Further evaluation of diagnostic performance of various assays could improve current CD diagnostic algorithms and proper care management in these regions. Genetic variability in the parasite may also play a role in the differing assay performances seen in this study, and this may be a valuable avenue of further research.
- 11 January 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (1) , 8
Open AccessChagas Disease in Pregnant Women from Endemic Regions Attending the Hospital General de Mexico, Mexico City
Trypanosoma cruzi infection leads to Chagas disease (CD), a neglected tropical infection of significant public health importance in South and Central America and other, non-endemic, countries. Pregnant women and their children are of particular importance to screen as T. cruzi can be transmitted vertically. The objective of this study was to screen for T. cruzi infection among pregnant women from endemic areas seen at the Hospital General de Mexico for prenatal care, so that they and their children may be quickly connected to CD treatment. Pregnant women were recruited through the hospital prenatal clinic and screened for T. cruzi infection using a series of serological and molecular tests. Of 150 screened patients, mean age 26.8 (SD 6.4), 30 (20.0%) were positive by at least one diagnostic test. Of these, only nine (6%) were positive as determined by PCR. Diagnosis of chronic CD is difficult in endemic places like Mexico due to the limitations of current commercially available diagnostic tests. Further evaluation of diagnostic performance of various assays could improve current CD diagnostic algorithms and proper care management in these regions. Genetic variability in the parasite may also play a role in the differing assay performances seen in this study, and this may be a valuable avenue of further research.
- Open Access
- 1 January 2022
- Published by GRAPHIMEDIC SA DE CV in Revista CONAMED
- Vol. 27 (S1) , s47-52
Angioembolización en la placenta invasora
- 1 January 2022
- Published by GRAPHIMEDIC SA DE CV in Revista CONAMED
- Vol. 27 (S1) , s47-52
Open AccessAngioembolización en la placenta invasora
- Open Access
- 1 January 2022
- Published by GRAPHIMEDIC SA DE CV in Revista CONAMED
- Vol. 27 (S1) , s14-19
Eclampsia
La eclampsia se def ine como la ocurrencia de una o más convulsiones en asociación con el síndrome de la preeclampsia. La preeclampsia es un trastorno multisistémico que suele asociarse con proteinuria en el embarazo y la presión arterial elevada. La eclampsia es una forma extremadamente grave de preeclampsia, por lo que se constituye en una de las entidades patológicas de los cuadros hipertensivos del embarazo, de tal manera que es difícil comprender lo que es la eclampsia, sin estudiar previamente la preeclampsia, no está estrictamente relacionada con la gravedad del cuadro de preeclampsia, ya que pueden aparecer abruptamente las convulsiones incluso existiendo pocos signos de preeclampsia. La eclampsia se observa en 0.2-0.5% de todos los nacimientos y puede complicar hasta 1.5% de los embarazos gemelares. Ocurre en alrededor de 2-3% de los pacientes con preeclampsia y puede ser la característica que permite el diagnóstico de esta entidad. 1 La eclampsia se produce durante el anteparto en 46.3% de los casos, el intraparto en 16.4% y el postparto en 37.3%. DEFINICIÓN Eclampsia es la aparición de convulsiones tónico-clónicas durante el embarazo y el puerperio que no puede ser explicado por otra causa, como la epilepsia, la razón más común para las crisis convulsivas en mujeres embarazadas. Signos y síntomas premonitorios incluyendo dolor de cabeza, cambios visuales, hipertensión arterial, malestar epigástrico y proteinuria, están presentes en hasta cuatro quintas partes de las pacientes posteriormente eclámpticas, 2 aunque la mayoría de las pacientes con estas características no caben en las cifras.
- 1 January 2022
- Published by GRAPHIMEDIC SA DE CV in Revista CONAMED
- Vol. 27 (S1) , s14-19
Open AccessEclampsia
La eclampsia se def ine como la ocurrencia de una o más convulsiones en asociación con el síndrome de la preeclampsia. La preeclampsia es un trastorno multisistémico que suele asociarse con proteinuria en el embarazo y la presión arterial elevada. La eclampsia es una forma extremadamente grave de preeclampsia, por lo que se constituye en una de las entidades patológicas de los cuadros hipertensivos del embarazo, de tal manera que es difícil comprender lo que es la eclampsia, sin estudiar previamente la preeclampsia, no está estrictamente relacionada con la gravedad del cuadro de preeclampsia, ya que pueden aparecer abruptamente las convulsiones incluso existiendo pocos signos de preeclampsia. La eclampsia se observa en 0.2-0.5% de todos los nacimientos y puede complicar hasta 1.5% de los embarazos gemelares. Ocurre en alrededor de 2-3% de los pacientes con preeclampsia y puede ser la característica que permite el diagnóstico de esta entidad. 1 La eclampsia se produce durante el anteparto en 46.3% de los casos, el intraparto en 16.4% y el postparto en 37.3%. DEFINICIÓN Eclampsia es la aparición de convulsiones tónico-clónicas durante el embarazo y el puerperio que no puede ser explicado por otra causa, como la epilepsia, la razón más común para las crisis convulsivas en mujeres embarazadas. Signos y síntomas premonitorios incluyendo dolor de cabeza, cambios visuales, hipertensión arterial, malestar epigástrico y proteinuria, están presentes en hasta cuatro quintas partes de las pacientes posteriormente eclámpticas, 2 aunque la mayoría de las pacientes con estas características no caben en las cifras.
- Open Access
- 1 January 2022
- Published by GRAPHIMEDIC SA DE CV in Revista CONAMED
- Vol. 27 (S1) , s32-36
Hemorragia obstétrica y su manejo en la Unidad de Cuidados Intensivos Obstétricos
Año en el mundo ocurren 536,000 muertes maternas, de las cuales 140,000 son originadas por hemorragia y
- 1 January 2022
- Published by GRAPHIMEDIC SA DE CV in Revista CONAMED
- Vol. 27 (S1) , s32-36
Open AccessHemorragia obstétrica y su manejo en la Unidad de Cuidados Intensivos Obstétricos
Año en el mundo ocurren 536,000 muertes maternas, de las cuales 140,000 son originadas por hemorragia y